Severe dermatologic reactions reported after treatment with tocainide.
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000889:Anti-Arrhythmia Agents / Q000009:adverse effects*; D003873:Dermatitis, Exfoliative / Q000139:chemically induced; D003875:Drug Eruptions / Q000209:etiology*; D004892:Erythema Multiforme / Q000139:chemically induced; D005260:Female; D006801:Humans; D008012:Lidocaine / Q000009:adverse effects / Q000031:analogs & derivatives*; D008297:Male; D008875:Middle Aged; D011358:Product Surveillance, Postmarketing; D013262:Stevens-Johnson Syndrome / Q000139:chemically induced; D013280:Stomatitis / Q000139:chemically induced; D016677:Tocainide; D014481:United States
D000889:Anti-Arrhythmia Agents; D016677:Tocainide; D008012:Lidocaine